G 2622 (Terbutaline 5 mg)
Pill imprint G 2622 has been identified as Terbutaline sulfate 5 mg.
Terbutaline is used in the treatment of premature labor; asthma, acute; asthma, maintenance and belongs to the drug classes adrenergic bronchodilators, tocolytic agents. There is no proven risk in humans during pregnancy. Terbutaline 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- G 2622
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Adrenergic bronchodilators
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Global Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
hypromellose 2910 (6 mPa.s)
|NDC Code||Manufacturer / Repackager|
|43063-0059||PDRX Pharmaceuticals Inc (repackager)|
|21695-0121||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about terbutaline
- Terbutaline tablets
- Terbutaline (Advanced Reading)
- Terbutaline Subcutaneous (Advanced Reading)
- Other brands: Brethine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.